Not the first time we have missed dates!
It is clear we will go past Sept 30, but the statement is that negotiations will continue into Q4 - what we don't know is how far. 2 weeks? 2 Months?
They may even have an in-principle agreement on the table subject to FDA orphan drug designation for NNZ-2591 and things may move quickly once this comes through. Who knows?
I expect the SP to ramp again once the FDA decision is released.
Ann: Neuren approaching key milestones in Q4 2019, page-85
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |